ciprofloxacin has been researched along with Eye Diseases in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Eye Diseases: Diseases affecting the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicenter, prospective clinical study of 148 culture-proven cases of bacterial keratitis, treated with ciprofloxacin 0." | 9.07 | Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. ( Leibowitz, HM, 1991) |
| "The authors compare the intravitreal efficacy of ciprofloxacin, vancomycin and imipenem, in treating experimental Bacillus cereus endophthalmitis." | 7.69 | Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. ( Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ, 1996) |
| "Ciprofloxacin is a potent fluoroquinolone antibiotic with in vitro activity against many significant gram-positive and gram-negative ocular pathogens." | 6.38 | Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. ( Cokingtin, CD; Hyndiuk, RA, 1991) |
| "A multicenter, prospective clinical study of 148 culture-proven cases of bacterial keratitis, treated with ciprofloxacin 0." | 5.07 | Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. ( Leibowitz, HM, 1991) |
| "The authors compare the intravitreal efficacy of ciprofloxacin, vancomycin and imipenem, in treating experimental Bacillus cereus endophthalmitis." | 3.69 | Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem. ( Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ, 1996) |
| "Ciprofloxacin is a potent fluoroquinolone antibiotic with in vitro activity against many significant gram-positive and gram-negative ocular pathogens." | 2.38 | Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. ( Cokingtin, CD; Hyndiuk, RA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tosco-Núñez, T | 1 |
| Bolaños-Rivero, M | 1 |
| Herman, E | 1 |
| Pérez-Álvarez, J | 1 |
| Accorinti, M | 1 |
| Espínola, M | 1 |
| Somodevilla, A | 1 |
| Domingo, D | 1 |
| Alarcón, T | 1 |
| López-Brea, M | 1 |
| Pijls, RT | 1 |
| Cruysberg, LP | 1 |
| Nuijts, RM | 1 |
| Dias, AA | 1 |
| Koole, LH | 1 |
| Alfaro, DV | 1 |
| Hudson, SJ | 1 |
| offele, JJ | 1 |
| Bevin, AA | 1 |
| Mines, M | 1 |
| Laughlin, RM | 1 |
| Schoderbek, RJ | 1 |
| Cokingtin, CD | 1 |
| Hyndiuk, RA | 1 |
| Leibowitz, HM | 1 |
| Bron, A | 1 |
| Talon, D | 1 |
| Cellier, T | 1 |
| Estavoyer, JM | 1 |
| Delbosc, B | 1 |
| Royer, J | 1 |
| Mounier, M | 1 |
| Adenis, JP | 1 |
| Denis, F | 1 |
1 review available for ciprofloxacin and Eye Diseases
| Article | Year |
|---|---|
Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections.
Topics: Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Eye Diseases; Humans; Keratitis; Ps | 1991 |
3 trials available for ciprofloxacin and Eye Diseases
| Article | Year |
|---|---|
Capacity and tolerance of a new device for ocular drug delivery.
Topics: Adult; Anti-Infective Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Carriers; Drug Compound | 2007 |
[Ciprofloxacin eyedrops. Ciprofloxacin for topical therapy].
Topics: Ciprofloxacin; Conjunctivitis; Eye Diseases; Humans; Keratitis; Ophthalmic Solutions | 1995 |
Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.
Topics: Bacterial Infections; Chemical Precipitation; Ciprofloxacin; Cornea; Crystallization; Eye Diseases; | 1991 |
6 other studies available for ciprofloxacin and Eye Diseases
| Article | Year |
|---|---|
[Keratitis due to Moraxella lacunata: a case report].
Topics: Anti-Bacterial Agents; Botulinum Toxins; Ciprofloxacin; Conjunctivitis; Eye Diseases; Female; Humans | 2013 |
Ocular bartonellosis.
Topics: Animals; Anti-Bacterial Agents; Bartonella Infections; Ciprofloxacin; Doxycycline; Erythromycin; Eye | 2009 |
[Antibiotic susceptibility of Corynebacterium macginleyi strains causing conjunctivitis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Conjunctiva; Conjunctivitis; C | 2010 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Cipr | 1996 |
[Intra aqueous humor penetration of ciprofloxacin in humans].
Topics: Aged; Aged, 80 and over; Aqueous Humor; Bacterial Infections; Cataract; Cataract Extraction; Ciprofl | 1989 |
[Intraocular penetration of ciprofloxacin after infusion and oral administration].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aqueous Humor; Ciprofloxacin; Eye; Eye Disease | 1988 |